India biz may stabilise in FY19, but govt price caps a concern: Sun Pharma
The company's India business revenues stood at Rs 80.29 billion in 2017-18, a growth of 4 per cent over 2016-17
The company's India business revenues stood at Rs 80.29 billion in 2017-18, a growth of 4 per cent over 2016-17